Clinical advancements expanding the potential of CAR T-cell therapies
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers, but further innovations are needed before the technology can reach its full potential. In this whitepaper, we explore the most exciting clinical developments in CAR T-cell therapy, and relate them to limitations of approved therapies, including safety, efficacy and logistics.
Promising developments in the field include innovative approaches to CAR T-cell therapy design and delivery:
We discuss how these innovations could help address pressing research questions:
Approaching the CAR T-cell therapy horizon